Many parents said they were afraid of noninvasive ventilation, with some citing inaccurate concerns about ventilation devices.

Capricor Therapeutics (NASDAQ:CAPR) received the Orphan Drug designation from the U.S. FDA for its lead cell therapy candidate, Deramiocel, to treat becker muscular dystrophy. With its orphan drug ...

Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...

SAN DIEGO - Capricor Therapeutics (NASDAQ:CAPR), een biotechnologiebedrijf met een marktkapitalisatie van $ 566 mln. en sterke liquiditeitsratio’s, maakte dinsdag bekend dat de U.S. Food and Drug Admi ...

U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s ...

Benzinga's options scanner spotted 10 options trades for Capricor Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 20% bullish and 70% bearish. Among ...

Volgens H.C. Wainwright heeft Capricor tot maandag geen directe kennisgeving van de FDA ontvangen over wijzigingen in de adviescomitévergadering. Het bedrijf merkte op dat dit een administratieve ...

Three years after litigation started over technology used in Comirnaty, the mRNA vaccine for COVID-19, Biontech SE is acquiring its adversary, Curevac NV, through an all-stock transaction valued at ...

Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San ...

Capricor Therapeutics' rating was downgraded amid FDA inspection risks, regulatory uncertainty, and potential delays in ...